1 Study Coverage 1.1 Direct-to-consumer Disease Risk and Health Test Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Introduction 1.2 Global Direct-to-consumer Disease Risk and Health Test Outlook 2017 VS 2022 VS 2028 1.2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size for the Year 2017-2028 1.2.2 Global Direct-to-consumer Disease Risk and Health Test Market Size for the Year 2017-2028 1.3 Direct-to-consumer Disease Risk and Health Test Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Direct-to-consumer Disease Risk and Health Test in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Direct-to-consumer Disease Risk and Health Test Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Direct-to-consumer Disease Risk and Health Test Market Dynamics 1.4.1 Direct-to-consumer Disease Risk and Health Test Industry Trends 1.4.2 Direct-to-consumer Disease Risk and Health Test Market Drivers 1.4.3 Direct-to-consumer Disease Risk and Health Test Market Challenges 1.4.4 Direct-to-consumer Disease Risk and Health Test Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Direct-to-consumer Disease Risk and Health Test by Type 2.1 Direct-to-consumer Disease Risk and Health Test Market Segment by Type 2.1.1 Celiac Disease 2.1.2 Parkinson Disease 2.1.3 Alzheimer Disease 2.1.4 Other 2.2 Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017, 2022 & 2028) 2.3 Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2028) 2.4 United States Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017, 2022 & 2028) 2.5 United States Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2028) 3 Direct-to-consumer Disease Risk and Health Test by Application 3.1 Direct-to-consumer Disease Risk and Health Test Market Segment by Application 3.1.1 Online 3.1.2 Offline 3.2 Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017, 2022 & 2028) 3.3 Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2028) 3.4 United States Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017, 2022 & 2028) 3.5 United States Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2028) 4 Global Direct-to-consumer Disease Risk and Health Test Competitor Landscape by Company 4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size by Company 4.1.1 Top Global Direct-to-consumer Disease Risk and Health Test Companies Ranked by Revenue (2021) 4.1.2 Global Direct-to-consumer Disease Risk and Health Test Revenue by Player (2017-2022) 4.2 Global Direct-to-consumer Disease Risk and Health Test Concentration Ratio (CR) 4.2.1 Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Direct-to-consumer Disease Risk and Health Test in 2021 4.2.3 Global Direct-to-consumer Disease Risk and Health Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Direct-to-consumer Disease Risk and Health Test Headquarters, Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Type 4.3.1 Global Direct-to-consumer Disease Risk and Health Test Headquarters and Area Served 4.3.2 Global Direct-to-consumer Disease Risk and Health Test Companies Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Direct-to-consumer Disease Risk and Health Test Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Direct-to-consumer Disease Risk and Health Test Market Size by Company 4.5.1 Top Direct-to-consumer Disease Risk and Health Test Players in United States, Ranked by Revenue (2021) 4.5.2 United States Direct-to-consumer Disease Risk and Health Test Revenue by Players (2020, 2021 & 2022) 5 Global Direct-to-consumer Disease Risk and Health Test Market Size by Region 5.1 Global Direct-to-consumer Disease Risk and Health Test Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (2017-2028) 5.2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size by Region: 2017-2022 5.2.2 Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth 2017-2028 6.1.2 North America Direct-to-consumer Disease Risk and Health Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth 2017-2028 6.3.2 Europe Direct-to-consumer Disease Risk and Health Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth 2017-2028 6.4.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 23andMe 7.1.1 23andMe Company Details 7.1.2 23andMe Business Overview 7.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Introduction 7.1.4 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.1.5 23andMe Recent Development 7.2 MyHeritage 7.2.1 MyHeritage Company Details 7.2.2 MyHeritage Business Overview 7.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Introduction 7.2.4 MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.2.5 MyHeritage Recent Development 7.3 LabCorp 7.3.1 LabCorp Company Details 7.3.2 LabCorp Business Overview 7.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Introduction 7.3.4 LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.3.5 LabCorp Recent Development 7.4 Myriad Genetics 7.4.1 Myriad Genetics Company Details 7.4.2 Myriad Genetics Business Overview 7.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Introduction 7.4.4 Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.4.5 Myriad Genetics Recent Development 7.5 Ancestry.com 7.5.1 Ancestry.com Company Details 7.5.2 Ancestry.com Business Overview 7.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Introduction 7.5.4 Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.5.5 Ancestry.com Recent Development 7.6 Quest Diagnostics 7.6.1 Quest Diagnostics Company Details 7.6.2 Quest Diagnostics Business Overview 7.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Introduction 7.6.4 Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.6.5 Quest Diagnostics Recent Development 7.7 Gene By Gene 7.7.1 Gene By Gene Company Details 7.7.2 Gene By Gene Business Overview 7.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Introduction 7.7.4 Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.7.5 Gene By Gene Recent Development 7.8 DNA Diagnostics Center 7.8.1 DNA Diagnostics Center Company Details 7.8.2 DNA Diagnostics Center Business Overview 7.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Introduction 7.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.8.5 DNA Diagnostics Center Recent Development 7.9 Invitae 7.9.1 Invitae Company Details 7.9.2 Invitae Business Overview 7.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Introduction 7.9.4 Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.9.5 Invitae Recent Development 7.10 IntelliGenetics 7.10.1 IntelliGenetics Company Details 7.10.2 IntelliGenetics Business Overview 7.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Introduction 7.10.4 IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.10.5 IntelliGenetics Recent Development 7.11 Ambry Genetics 7.11.1 Ambry Genetics Company Details 7.11.2 Ambry Genetics Business Overview 7.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Introduction 7.11.4 Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.11.5 Ambry Genetics Recent Development 7.12 Living DNA 7.12.1 Living DNA Company Details 7.12.2 Living DNA Business Overview 7.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Introduction 7.12.4 Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.12.5 Living DNA Recent Development 7.13 EasyDNA 7.13.1 EasyDNA Company Details 7.13.2 EasyDNA Business Overview 7.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Introduction 7.13.4 EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.13.5 EasyDNA Recent Development 7.14 Pathway Genomics 7.14.1 Pathway Genomics Company Details 7.14.2 Pathway Genomics Business Overview 7.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Introduction 7.14.4 Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.14.5 Pathway Genomics Recent Development 7.15 Centrillion Technology 7.15.1 Centrillion Technology Company Details 7.15.2 Centrillion Technology Business Overview 7.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Introduction 7.15.4 Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.15.5 Centrillion Technology Recent Development 7.16 Xcode 7.16.1 Xcode Company Details 7.16.2 Xcode Business Overview 7.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Introduction 7.16.4 Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.16.5 Xcode Recent Development 7.17 Color Genomics 7.17.1 Color Genomics Company Details 7.17.2 Color Genomics Business Overview 7.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Introduction 7.17.4 Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.17.5 Color Genomics Recent Development 7.18 Anglia DNA Services 7.18.1 Anglia DNA Services Company Details 7.18.2 Anglia DNA Services Business Overview 7.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Introduction 7.18.4 Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.18.5 Anglia DNA Services Recent Development 7.19 African Ancestry 7.19.1 African Ancestry Company Details 7.19.2 African Ancestry Business Overview 7.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Introduction 7.19.4 African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.19.5 African Ancestry Recent Development 7.20 Canadian DNA Services 7.20.1 Canadian DNA Services Company Details 7.20.2 Canadian DNA Services Business Overview 7.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Introduction 7.20.4 Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.20.5 Canadian DNA Services Recent Development 7.21 DNA Family Check 7.21.1 DNA Family Check Company Details 7.21.2 DNA Family Check Business Overview 7.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Introduction 7.21.4 DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.21.5 DNA Family Check Recent Development 7.22 Alpha Biolaboratories 7.22.1 Alpha Biolaboratories Company Details 7.22.2 Alpha Biolaboratories Business Overview 7.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Introduction 7.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.22.5 Alpha Biolaboratories Recent Development 7.23 Test Me DNA 7.23.1 Test Me DNA Company Details 7.23.2 Test Me DNA Business Overview 7.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Introduction 7.23.4 Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.23.5 Test Me DNA Recent Development 7.24 23 Mofang 7.24.1 23 Mofang Company Details 7.24.2 23 Mofang Business Overview 7.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Introduction 7.24.4 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.24.5 23 Mofang Recent Development 7.25 Genetic Health 7.25.1 Genetic Health Company Details 7.25.2 Genetic Health Business Overview 7.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Introduction 7.25.4 Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.25.5 Genetic Health Recent Development 7.26 DNA Services of America 7.26.1 DNA Services of America Company Details 7.26.2 DNA Services of America Business Overview 7.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Introduction 7.26.4 DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.26.5 DNA Services of America Recent Development 7.27 Shuwen Health Sciences 7.27.1 Shuwen Health Sciences Company Details 7.27.2 Shuwen Health Sciences Business Overview 7.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Introduction 7.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.27.5 Shuwen Health Sciences Recent Development 7.28 Mapmygenome 7.28.1 Mapmygenome Company Details 7.28.2 Mapmygenome Business Overview 7.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Introduction 7.28.4 Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.28.5 Mapmygenome Recent Development 7.29 Full Genomes 7.29.1 Full Genomes Company Details 7.29.2 Full Genomes Business Overview 7.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Introduction 7.29.4 Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) 7.29.5 Full Genomes Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Direct-to-consumer Disease Risk and Health Test Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Direct-to-consumer Disease Risk and Health Test Market Trends Table 3. Direct-to-consumer Disease Risk and Health Test Market Drivers Table 4. Direct-to-consumer Disease Risk and Health Test Market Challenges Table 5. Direct-to-consumer Disease Risk and Health Test Market Restraints Table 6. Global Direct-to-consumer Disease Risk and Health Test Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Direct-to-consumer Disease Risk and Health Test Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Direct-to-consumer Disease Risk and Health Test Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Direct-to-consumer Disease Risk and Health Test Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Direct-to-consumer Disease Risk and Health Test Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Direct-to-consumer Disease Risk and Health Test Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Player, 2017-2022 Table 13. Global Direct-to-consumer Disease Risk and Health Test Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Direct-to-consumer Disease Risk and Health Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2021) Table 15. Top Players of Direct-to-consumer Disease Risk and Health Test in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Direct-to-consumer Disease Risk and Health Test Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Direct-to-consumer Disease Risk and Health Test Players in United States Market, Ranking by Revenue (2021) Table 20. United States Direct-to-consumer Disease Risk and Health Test Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Direct-to-consumer Disease Risk and Health Test Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Direct-to-consumer Disease Risk and Health Test Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Direct-to-consumer Disease Risk and Health Test Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Direct-to-consumer Disease Risk and Health Test Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Direct-to-consumer Disease Risk and Health Test Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Sales in Value by Country (2017-2028) & (US$ Million) Table 30. 23andMe Company Details Table 31. 23andMe Business Overview Table 32. 23andMe Direct-to-consumer Disease Risk and Health Test Product Table 33. 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 34. 23andMe Recent Development Table 35. MyHeritage Company Details Table 36. MyHeritage Business Overview Table 37. MyHeritage Direct-to-consumer Disease Risk and Health Test Product Table 38. MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 39. MyHeritage Recent Development Table 40. LabCorp Company Details Table 41. LabCorp Business Overview Table 42. LabCorp Direct-to-consumer Disease Risk and Health Test Product Table 43. LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 44. LabCorp Recent Development Table 45. Myriad Genetics Company Details Table 46. Myriad Genetics Business Overview Table 47. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Product Table 48. Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 49. Myriad Genetics Recent Development Table 50. Ancestry.com Company Details Table 51. Ancestry.com Business Overview Table 52. Ancestry.com Direct-to-consumer Disease Risk and Health Test Product Table 53. Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 54. Ancestry.com Recent Development Table 55. Quest Diagnostics Company Details Table 56. Quest Diagnostics Business Overview Table 57. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Product Table 58. Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 59. Quest Diagnostics Recent Development Table 60. Gene By Gene Company Details Table 61. Gene By Gene Business Overview Table 62. Gene By Gene Direct-to-consumer Disease Risk and Health Test Product Table 63. Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 64. Gene By Gene Recent Development Table 65. DNA Diagnostics Center Company Details Table 66. DNA Diagnostics Center Business Overview Table 67. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Product Table 68. DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 69. DNA Diagnostics Center Recent Development Table 70. Invitae Company Details Table 71. Invitae Business Overview Table 72. Invitae Direct-to-consumer Disease Risk and Health Test Product Table 73. Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 74. Invitae Recent Development Table 75. IntelliGenetics Company Details Table 76. IntelliGenetics Business Overview Table 77. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product Table 78. IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 79. IntelliGenetics Recent Development Table 80. Ambry Genetics Company Details Table 81. Ambry Genetics Business Overview Table 82. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Product Table 83. Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 84. Ambry Genetics Recent Development Table 85. Living DNA Company Details Table 86. Living DNA Business Overview Table 87. Living DNA Direct-to-consumer Disease Risk and Health Test Product Table 88. Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 89. Living DNA Recent Development Table 90. EasyDNA Company Details Table 91. EasyDNA Business Overview Table 92. EasyDNA Direct-to-consumer Disease Risk and Health Test Product Table 93. EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 94. EasyDNA Recent Development Table 95. Pathway Genomics Company Details Table 96. Pathway Genomics Business Overview Table 97. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Product Table 98. Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 99. Pathway Genomics Recent Development Table 100. Centrillion Technology Company Details Table 101. Centrillion Technology Business Overview Table 102. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Product Table 103. Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 104. Centrillion Technology Recent Development Table 105. Xcode Company Details Table 106. Xcode Business Overview Table 107. Xcode Direct-to-consumer Disease Risk and Health Test Product Table 108. Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 109. Xcode Recent Development Table 110. Color Genomics Company Details Table 111. Color Genomics Business Overview Table 112. Color Genomics Direct-to-consumer Disease Risk and Health Test Product Table 113. Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 114. Color Genomics Recent Development Table 115. Anglia DNA Services Company Details Table 116. Anglia DNA Services Business Overview Table 117. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Product Table 118. Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 119. Anglia DNA Services Recent Development Table 120. African Ancestry Company Details Table 121. African Ancestry Business Overview Table 122. African Ancestry Direct-to-consumer Disease Risk and Health Test Product Table 123. African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 124. African Ancestry Recent Development Table 125. Canadian DNA Services Company Details Table 126. Canadian DNA Services Business Overview Table 127. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Product Table 128. Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 129. Canadian DNA Services Recent Development Table 130. DNA Family Check Company Details Table 131. DNA Family Check Business Overview Table 132. DNA Family Check Direct-to-consumer Disease Risk and Health Test Product Table 133. DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 134. DNA Family Check Recent Development Table 135. Alpha Biolaboratories Company Details Table 136. Alpha Biolaboratories Business Overview Table 137. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Product Table 138. Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 139. Alpha Biolaboratories Recent Development Table 140. Test Me DNA Company Details Table 141. Test Me DNA Business Overview Table 142. Test Me DNA Direct-to-consumer Disease Risk and Health Test Product Table 143. Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 144. Test Me DNA Recent Development Table 145. 23 Mofang Company Details Table 146. 23 Mofang Business Overview Table 147. 23 Mofang Direct-to-consumer Disease Risk and Health Test Product Table 148. 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 149. 23 Mofang Recent Development Table 150. Genetic Health Company Details Table 151. Genetic Health Business Overview Table 152. Genetic Health Direct-to-consumer Disease Risk and Health Test Product Table 153. Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 154. Genetic Health Recent Development Table 155. DNA Services of America Company Details Table 156. DNA Services of America Business Overview Table 157. DNA Services of America Direct-to-consumer Disease Risk and Health Test Product Table 158. DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 159. DNA Services of America Recent Development Table 160. Shuwen Health Sciences Company Details Table 161. Shuwen Health Sciences Business Overview Table 162. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Product Table 163. Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 164. Shuwen Health Sciences Recent Development Table 165. Mapmygenome Company Details Table 166. Mapmygenome Business Overview Table 167. Mapmygenome Direct-to-consumer Disease Risk and Health Test Product Table 168. Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 169. Mapmygenome Recent Development Table 170. Full Genomes Company Details Table 171. Full Genomes Business Overview Table 172. Full Genomes Direct-to-consumer Disease Risk and Health Test Product Table 173. Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million) Table 174. Full Genomes Recent Development Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. Direct-to-consumer Disease Risk and Health Test Product Picture Figure 2. Global Direct-to-consumer Disease Risk and Health Test Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Direct-to-consumer Disease Risk and Health Test Market Size 2017-2028 (US$ Million) Figure 4. United States Direct-to-consumer Disease Risk and Health Test Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Direct-to-consumer Disease Risk and Health Test Market Size 2017-2028 (US$ Million) Figure 6. United States Direct-to-consumer Disease Risk and Health Test Market Share in Global 2017-2028 Figure 7. Direct-to-consumer Disease Risk and Health Test Report Years Considered Figure 8. Product Picture of Celiac Disease Figure 9. Product Picture of Parkinson Disease Figure 10. Product Picture of Alzheimer Disease Figure 11. Product Picture of Other Figure 12. Global Direct-to-consumer Disease Risk and Health Test Market Share by Type in 2022 & 2028 Figure 13. Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2028) & (US$ Million) Figure 14. Global Direct-to-consumer Disease Risk and Health Test Market Share by Type (2017-2028) Figure 15. United States Direct-to-consumer Disease Risk and Health Test Market Share by Type in 2022 & 2028 Figure 16. United States Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2028) & (US$ Million) Figure 17. United States Direct-to-consumer Disease Risk and Health Test Market Share by Type (2017-2028) Figure 18. Product Picture of Online Figure 19. Product Picture of Offline Figure 20. Global Direct-to-consumer Disease Risk and Health Test Market Share by Application in 2022 & 2028 Figure 21. Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2028) & (US$ Million) Figure 22. Global Direct-to-consumer Disease Risk and Health Test Market Share by Application (2017-2028) Figure 23. United States Direct-to-consumer Disease Risk and Health Test Market Share by Application in 2022 & 2028 Figure 24. United States Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2028) & (US$ Million) Figure 25. United States Direct-to-consumer Disease Risk and Health Test Market Share by Application (2017-2028) Figure 26. North America Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate 2017-2028 (US$ Million) Figure 27. U.S. Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Canada Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Europe Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. Germany Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. France Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. U.K. Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Italy Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Russia Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate 2017-2028 (US$ Million) Figure 36. China Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Japan Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. South Korea Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. India Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Australia Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Taiwan Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Indonesia Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Thailand Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Malaysia Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Philippines Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. U.A.E Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. 23andMe Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 55. MyHeritage Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 56. LabCorp Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 57. Myriad Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 58. Ancestry.com Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 59. Quest Diagnostics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 60. Gene By Gene Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 61. DNA Diagnostics Center Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 62. Invitae Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 63. IntelliGenetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 64. Ambry Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 65. Living DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 66. EasyDNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 67. Pathway Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 68. Centrillion Technology Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 69. Xcode Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 70. Color Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 71. Anglia DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 72. African Ancestry Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 73. Canadian DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 74. DNA Family Check Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 75. Alpha Biolaboratories Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 76. Test Me DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 77. 23 Mofang Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 78. Genetic Health Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 79. DNA Services of America Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 80. Shuwen Health Sciences Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 81. Mapmygenome Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 82. Full Genomes Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

23andMe MyHeritage LabCorp Myriad Genetics Ancestry.com Quest Diagnostics Gene By Gene DNA Diagnostics Center Invitae IntelliGenetics Ambry Genetics Living DNA EasyDNA Pathway Genomics Centrillion Technology Xcode Color Genomics Anglia DNA Services African Ancestry Canadian DNA Services DNA Family Check Alpha Biolaboratories Test Me DNA 23 Mofang Genetic Health DNA Services of America Shuwen Health Sciences Mapmygenome Full Genomes